Nauzene
Active substance: trisodium citrate
TABLET, CHEWABLE · TRISODIUM CITRATE DIHYDRATE 230 mg/1
United StatesActive
Marketing holder: Kobayashi Healthcare International, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- TRISODIUM CITRATE DIHYDRATE · 230 mg/1
Registration
- Registration number
- 52389-242
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- ORAL
Sources
- product · openFDA NDC · 52389-242 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 52389-242 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 52389-242 · Verified 2026-10-09 · open in source